【レポートの概要（一部）】
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.3. Market share analysis, 2018
3.4. Market dynamics
3.4.1. Impact analyses
3.4.2. Drivers
3.4.2.1. Low expenditure on healthcare
3.4.2.2. Assured improvement in patient safety outcomes
3.4.2.3. Benefits of medical simulation
3.4.2.4. Technological advancements in medical field
3.4.3. Restraints
3.4.3.1. High cost of setting up simulators
3.4.3.2. Limitation of a complete real situation
3.4.4. Opportunities
3.4.4.1. Lucrative opportunities in emerging markets
CHAPTER 4: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE
4.1. Overview
4.1.1. Market size and forecast
4.2. Model-based simulation
4.2.1. Market size and forecast by type
4.2.1.1. Patient simulation
4.2.1.1.1. Market size and forecast
4.2.1.1.1.1. Task trainer simulation: Market Size and Forecast
4.2.1.1.1.2. Manikin-based simulation: Market Size and Forecast
4.2.1.1.1.3. Standardized Patient Simulation: Market Size and Forecast
4.2.1.2. Surgical simulation
4.2.1.2.1. Market size and forecast
4.2.1.2.1.1. Laparoscopic Surgical Simulators: Market Size and Forecast
4.2.1.2.1.2. Arthroscopic Surgical Simulators: Market Size and Forecast
4.2.1.2.1.3. Cardiovascular Simulators: Market Size and Forecast
4.2.1.2.1.4. Gynecology Simulators: Market Size and Forecast
4.2.1.2.1.5. Others: Market Size and Forecast
4.2.1.3. Ultrasound simulation
4.2.1.3.1. Market size and forecast
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Web-based simulation
4.3.1. Market size and forecast by type
4.3.1.1. Simulation Software: Market Size and Forecast
4.3.1.2. Performance Recording Software: Market Size and Forecast
4.3.1.3. Virtual Tutors: Market Size and Forecast
4.3.2. Market size and forecast by region
4.3.3. Market analysis, by country
4.4. Simulation Training Services
4.4.1. Market size and forecast by type
4.4.1.1. Vendor-based Training: Market Size and Forecast
4.4.1.2. Custom Consulting Services: Market Size and Forecast
4.4.1.3. Educational Societies: Market Size and Forecast
4.4.2. Market size and forecast by region
4.4.3. Market analysis, by country
CHAPTER 5: MEDICAL SIMULATION MARKET, BY FIDELITY
5.1. Overview
5.1.1. Market size and forecast
5.2. Low-fidelity
5.2.1. Market size and forecast by region
5.2.2. Market analysis, by country
5.3. Medium-fidelity
5.3.1. Market size and forecast by region
5.3.2. Market analysis, by country
5.4. High-fidelity
5.4.1. Market size and forecast by region
5.4.2. Market analysis, by country
CHAPTER 6: MEDICAL SIMULATION MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Academic Institutions & Research Centers
6.2.1. Market size and forecast by region
6.2.2. Market analysis, by country
6.2.2.1. Medical Academia: Market Size and Forecast
6.2.2.2. Nursing: Market Size and Forecast
6.2.2.3. Emergency Medical Services: Market Size and Forecast
6.3. Hospitals & Clinics
6.3.1. Market size and forecast by region
6.3.2. Market analysis, by country
6.4. Military Organizations
6.4.1. Market size and forecast by region
6.4.2. Market analysis, by country
CHAPTER 7: MEDICAL SIMULATION, BY REGION
7.1. Market size and forecast
7.2. North America
7.2.1. North America: Market Size and Forecast, by country
7.2.1.1. U.S. medical simulation: Market Size and Forecast
7.2.1.1.1. U.S. medical simulation: market size and forecast by product & service
7.2.1.1.2. U.S. medical simulation: market size and forecast by fidelity
7.2.1.1.3. U.S. medical simulation: market size and forecast by end user
7.2.1.2. Canada medical simulation: Market Size and Forecast
7.2.1.2.1. Canada medical simulation: market size and forecast by product & service
7.2.1.2.2. Canada medical simulation: market size and forecast by fidelity
7.2.1.2.3. Canada medical simulation: market size and forecast by end user
7.2.1.3. Mexico medical simulation: Market Size and Forecast
7.2.1.3.1. Mexico medical simulation: market size and forecast by product & service
7.2.1.3.2. Mexico medical simulation: market size and forecast by fidelity
7.2.1.3.3. Mexico medical simulation: market size and forecast by end user
7.2.2. North America: market size and forecast by product & service
7.2.3. North America: market size and forecast by fidelity
7.2.4. North America: market size and forecast by end user
7.3. Europe
7.3.1. Europe: Market Size and Forecast, by country
7.3.1.1. Germany medical simulation: Market Size and Forecast
7.3.1.1.1. Germany medical simulation: market size and forecast by product & service
7.3.1.1.2. Germany medical simulation: market size and forecast by fidelity
7.3.1.1.3. Germany medical simulation: market size and forecast by end user
7.3.1.2. France medical simulation: Market Size and Forecast
7.3.1.2.1. France medical simulation: market size and forecast by product & service
7.3.1.2.2. France medical simulation: market size and forecast by fidelity
7.3.1.2.3. France medical simulation: market size and forecast by end user
7.3.1.3. UK medical simulation: Market Size and Forecast
7.3.1.3.1. UK medical simulation: market size and forecast by product & service
7.3.1.3.2. UK medical simulation: market size and forecast by fidelity
7.3.1.3.3. UK medical simulation: market size and forecast by end user
7.3.1.4. Italy medical simulation: Market Size and Forecast
7.3.1.4.1. Italy medical simulation: market size and forecast by product & service
7.3.1.4.2. Italy medical simulation: market size and forecast by fidelity
7.3.1.4.3. Italy medical simulation: market size and forecast by end user
7.3.1.5. Spain medical simulation: Market Size and Forecast
7.3.1.5.1. Spain medical simulation: market size and forecast by product & service
7.3.1.5.2. Spain medical simulation: market size and forecast by fidelity
7.3.1.5.3. Spain medical simulation: market size and forecast by end user
7.3.1.6. Rest of Europe medical simulation: Market Size and Forecast
7.3.1.6.1. Rest of Europe medical simulation: market size and forecast by product & service
7.3.1.6.2. Rest of Europe medical simulation: market size and forecast by fidelity
7.3.1.6.3. Rest of Europe medical simulation: market size and forecast by end user
7.3.2. Europe: market size and forecast by product & service
7.3.3. Europe: market size and forecast by fidelity
7.3.4. Europe: market size and forecast by end user
7.4. Asia-pacific
7.4.1. Asia-pacific: Market Size and Forecast, by country
7.4.1.1. Japan medical simulation: Market Size and Forecast
7.4.1.1.1. Japan medical simulation: market size and forecast by product & service
7.4.1.1.2. Japan medical simulation: market size and forecast by fidelity
7.4.1.1.3. Japan medical simulation: market size and forecast by end user
7.4.1.2. China medical simulation: Market Size and Forecast
7.4.1.2.1. China medical simulation: market size and forecast by product & service
7.4.1.2.2. China medical simulation: market size and forecast by fidelity
7.4.1.2.3. China medical simulation: market size and forecast by end user
7.4.1.3. India medical simulation: Market Size and Forecast
7.4.1.3.1. India medical simulation: market size and forecast by product & service
7.4.1.3.2. India medical simulation: market size and forecast by fidelity
7.4.1.3.3. India medical simulation: market size and forecast by end user
7.4.1.4. Australia medical simulation: Market Size and Forecast
7.4.1.4.1. Australia medical simulation: market size and forecast by product & service
7.4.1.4.2. Australia medical simulation: market size and forecast by fidelity
7.4.1.4.3. Australia medical simulation: market size and forecast by end user
7.4.1.5. Rest of Asia-pacific medical simulation: Market Size and Forecast
7.4.1.5.1. Rest of Asia-pacific medical simulation: market size and forecast by product & service
7.4.1.5.2. Rest of Asia-pacific medical simulation: market size and forecast by fidelity
7.4.1.5.3. Rest of Asia-pacific medical simulation: market size and forecast by end user
7.4.2. Asia-pacific: market size and forecast by product & service
7.4.3. Asia-pacific: market size and forecast by fidelity
7.4.4. Asia-pacific: market size and forecast by end user
7.5. LAMEA
7.5.1. LAMEA: Market Size and Forecast, by country
7.5.1.1. Brazil medical simulation: Market Size and Forecast
7.5.1.1.1. Brazil medical simulation: market size and forecast by product & service
7.5.1.1.2. Brazil medical simulation: market size and forecast by fidelity
7.5.1.1.3. Brazil medical simulation: market size and forecast by end user
7.5.1.2. South Africa medical simulation: Market Size and Forecast
7.5.1.2.1. South Africa medical simulation: market size and forecast by product & service
7.5.1.2.2. South Africa medical simulation: market size and forecast by fidelity
7.5.1.2.3. South Africa medical simulation: market size and forecast by end user
7.5.1.3. Saudi Arabia medical simulation: Market Size and Forecast
7.5.1.3.1. Saudi Arabia medical simulation: market size and forecast by product & service
7.5.1.3.2. Saudi Arabia medical simulation: market size and forecast by fidelity
7.5.1.3.3. Saudi Arabia medical simulation: market size and forecast by end user
7.5.1.4. Rest of LAMEA medical simulation: Market Size and Forecast
7.5.1.4.1. Rest of LAMEA medical simulation: market size and forecast by product & service
7.5.1.4.2. Rest of LAMEA medical simulation: market size and forecast by fidelity
7.5.1.4.3. Rest of LAMEA medical simulation: market size and forecast by end user
7.5.2. LAMEA: market size and forecast by product & service
7.5.3. LAMEA: market size and forecast by fidelity
7.5.4. LAMEA: market size and forecast by end user
CHAPTER 8: COMPANY PROFILES
8.1. 3D SYSTEMS CORPORATION (SIMBIONIX)
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Business performance
8.1.4. Key strategic moves and developments
8.2. CAE INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Business performance
8.2.5. Key strategic moves and developments
8.3. GAUMARD SCIENTIFIC COMPANY
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Key strategic moves and developments
8.4. KYOTO KAGAKU CO. LTD.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.5. LAERDAL MEDICAL AS
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Key strategic moves and developments
8.6. LIMBS AND THINGS LTD.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Key strategic moves and developments
8.7. MENTICE AB
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Key strategic moves and developments
8.8. SIMULAB CORPORATION
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.9. SIMULAIDS INC.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Key strategic moves and developments
8.10. SURGICAL SCIENCE SWEDEN AB
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Business performance
8.10.4. Key strategic moves and developments
【レポート販売概要】
■ タイトル：医療用シミュレーションの世界市場：製品・サービス別（モデルベースシミュレーション、Webベースシミュレーション、シミュレーショントレーニングサービス）、フィデリティ別（低フィデリティ、中フィデリティ、高フィデリティ）、エンドユーザー別（学術機関・研究センター、病院・診療所、軍事組織）■ 英文：Medical Simulation Market by Product & Service (Model-based Simulation, Web-based simulation, and Simulation Training Services), Fidelity (Low-fidelity, Medium-fidelity, and High-Fidelity), and End User (Academic Institutes and Research Centers, Hospitals & Clinics, and Military Organizations): Global Opportunity Analysis and Industry Forecast, 2018–2025
■ 発行日：2019年6月19日
■ 調査会社：Allied Market Research
■ 商品コード：AMR9AG053
■ 調査対象地域：グローバル
- 生物除草剤の世界市場：微生物、生物化学品The market size for bioherbicides is projected to reach USD 1,573.7 Million by 2021, at a CAGR of around 14.5% from 2016. The global bioherbicides market has grown exponentially in the last few years. Asia-Pacifc countries such as China, Japan, and India are the primary targets of the industry. Increasing demand for organic products, reduced chemical hazards and easier residue management, improved …
- 世界の喘息治療市場：気管支拡張薬、ロイコトリエン拮抗薬、肥満細胞安定化薬、免疫抑制剤About Asthma and its Categories Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where the muscles around the respiratory tract swell up. The disease is believed to be caused by genetic as well as envir …
- 加工ジャガイモデンプンの世界市場2019-2023About this market The market has witnessed an increasing demand for precision farming in developed and developing countries, which will increase potato yield, and thereby improve the production of modified potato starches. The precision farming is a farming management technique that uses limited resources and factors such as low cost, limited availability of land, and improved farming practices. T …
- 食用潤滑油の世界市場：鉱物油、化学合成油、バイオ潤滑油Food grade lubricants are permitted for possible incidental contact with food products. The lubricants based on ingredients used are categorized as H1 (food grade lubricants, permitted for incidental contact), H2 (lubricants not permitted to have incidental contact), and H3 (soluble oils). The certification for this categorization is provided by organizations such as NSF International. Similarly, …
- 世界における小型自動車用ドアモジュール市場動向と予測（～2029）This latest just-auto report edition offers a global review of the OE door modules sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE door modules market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies and prosp …
- ANCA血管炎(Anca Vasculitis)：治療薬開発パイプライン動向（2015年上半期版）Anca Vasculitis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Anca Vasculitis - Pipeline Review, H1 2015’, provides an overview of the Anca Vasculitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Anca Vasculitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of acti …
- 単極誘導心電図用器具の世界市場：最終用途別（病院・診療所、在宅看護、外来外科センター）、表示別（不整脈、卒倒）、セグメント予測The global single lead ECG equipment market size is estimated to reach USD 487.59 million by 2025, progressing at a 4.72% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Emergence of smartphone and mobile-based cardiac monitoring devices has been revolutionized the market in the past few years. Medical device manufacturers continue to invest in development o …
- エリスロポエチン（EPO）薬の世界市場2017-2021ABSTRACTAbout Erythropoietin Drugs The global erythropoietin drugs market is expected to witness a slow growth rate during the forecast period. In 2016, EMEA dominated the market, followed by the Americas and APAC. India and China are the leading countries in the market in APAC. While Sandoz and Dr. Reddy's Laboratories dominate the erythropoietin (EPO) drugs market in India, the market in China i …
- クラウド型デスクトップ仮想化（VDI）ソリューションの世界市場About Cloud-based VDI A cloud-based VDI solution is a computing model where an end-user's system is separated from the physical IT infrastructure, but can access all the necessary files and data virtually. This computing model uses a cloud-based storage space, wherein the system applications and data are stored in the data center of a primary cloud service provider. End-users can gain remote acces …
- 世界の赤外線画像市場動向（2012-2016）TechNavio's analysts forecast the Global Infrared Imaging market to grow at a CAGR of 12.2 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need for increased energy savings. The Global Infrared Imaging market has also been witnessing the development of high-speed infrared cameras. However, the need for increased investment could pose a challenge …
- 発泡剤の世界市場予測（～2026年）“Growing use of polymer foam in industries such as construction, automotive, and electronics, to drive the blowing agent market”The blowing agent market size is estimated to be USD 1.5 billion in 2019 and is projected to reach USD 2.2 billion by 2026, at a CAGR of 5.8%. The increasing polymeric foam application in industries such as packaging, automotive, building & construction, marine, transport …
- 自動車用OEM塗料の世界市場：水溶性塗料、溶剤型塗料、粉末塗料、紫外線硬化塗料About Automotive OEM Coatings Automotive coatings are products that enhance the appearance and durability of a vehicle by protecting it from external factors such as UV radiation, extreme temperatures, and foreign particles such as stones, rubble, and debris. Automotive OEM coatings are used by automotive manufacturers for the production of new passenger cars, light commercial vehicles, and heavy …
- 世界のフィールドサービス管理（FSM）市場動向（2012-2016）TechNavio's analysts forecast the Global Field Service Management market to grow at a CAGR of 4 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rise in the demand for field service management solutions from small and medium-sized enterprises. The Global Field Service Management market has also been witnessing the emergence of software-as-a-servic …
- Continental Resources, Inc.：石油・ガスの開発・生産動向及びコスト分析– Q4, 2012Continental Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2012 Summary Continental Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an esse …
- 世界のモバイル広告市場分析、展望及び予測Mobile advertising has evolved beyond an experiment to become a legitimate marketing channel for mainstream advertisers. However, the mobile channels remains challenged in certain key areas such as certain industry vertical proof points and ROI. This research focuses on the challenges and opportunities within mobile marketing and advertising in 2014 and beyond. The report includes market analysis, …
